Supply Chain

The global interventional cardiology devices market will reach $11.2 billion by 2022, according to a report from Transparency Market Research.

Did you know that waste in the medical device and implantables supply chain amounts to an estimated $5 billion in losses, each year?1

The Medical Device Innovation Consortium developed a blueprint for early feasibility study success.

Wisconsin's Democratic lawmakers are drafting a proposal to control the cost of prescription drugs in the state, according to Wisconsin Public Radio.

The XSTAT hemostatic device was successfully used this week to clot a bleeding soldier's wound, marking the first documented clinical use of the tool.

Six months ago, the FDA ruled that a machine tied to a dangerous superbug outbreak needed to be taken off the market to protect public health. However, the machine remains in use after FDA officials backed down, according to Bloomberg.

A team of researchers from the National University of Singapore created a new tablet fabrication method that produces a single customizable pill specific to patients' needs.

Here are four key takeways on this growing market from Transparency Market Research.

A new proposal from Medicare to alter the way it pays for some drugs has sparked a large debate as to whether the plan gives too much power to government regulators over drug prices, according to PBS.

A group of physicians assembled Tuesday on behalf of the FDA to rule that St. Jude Medical's new heart device appears safe and effective in stroke prevention, according to the Minneapolis Star Tribune.